skip to primary navigationskip to content

Cambridge Service Alliance

developing new understanding and approaches to complex service systems

Studying at Cambridge

 

Ecosystems Evolution Enabled by Technology

Ecosystem evolution enabled by technology – an example in Healthcare

Healthcare is changing – fast

The search for new business models for the Pharmaceutical industry is being driven by a number of factors:

  1. Society’s healthcare burden is growing due to populations that are living longer (and being unwell for longer)
  2. Payors want to now pay for outcomes from medicines not just for the pills
  3. Generics (launched after patent expiry) are cutting the value of established brands and markets
  4. Pharma R&D is not producing the blockbusters companies have needed to support their revenues
  5. Pharmaceutical companies are looking to switch roles from being pure manufacturers to service providers delivering outcomes

 

Is personalised medicine finally here?

IBM’s Smarter Planet concept – that increasing instrumentation and interconnections are making the world more intelligent – shows that by connecting healthcare devices such as pill dispensers, and health monitoring devices (e.g. glucose meters, etc), insight can be gained to health at the individual, and population scale.

Such insight would benefit multiple stakeholders in the healthcare ecosystem:

Patients quantify their health outcomes, and Carers receive support through reminders. 
Healthcare providers gain insight to patient health, from which to recommend appropriate interventions.  Payors benefit from lower healthcare costs and focus on patient outcomes

New players are going to change the health ecosystem

The large-scale, long-term deployment of this approach, based on an extensive collaboration between healthcare and technology could deliver:

  1. Novel analytical techniques enabling patients, HCPs, and other stakeholders to act quickly 
  2. Accelerated incorporation of analytics using advanced, predictive capabilities for pattern and context recognition into health assessment
  3. Value-based pricing for medicines based on pseudo real-time health outcomes data that will radically alter the way in which medicines are developed and priced by the pharmaceutical industry.

Contact: Amer Fasihi

Filed under: , ,

RSS Feed Latest news

Webinar - Digital Business Transformation and Strategy

Feb 12, 2018

Webinar on 'Digital Business Transformation and Strategy: What do we know so far?' by Mariam Helmy Ismail Abdelaal

Wearable Sensor Technology and Business

Jan 25, 2018

Contextually Defined Postural Markers Reveal Who’s in Charge: Evidence from Small Teams Collected with Wearable Sensors by Julius Dietzel, R. Elena Francu, Benjamin Lucas, and Mohamed Zaki

Webinar - Big Data Analytics Architecture for Businesses

Jan 16, 2018

15 January 2018 - Big Data Analytics Architecture for Businesses - Open Source Perspective - Kerem Kayabay, Mert Golkalp, Mohamed Zaki

December Paper - Buyers Dependence and Financial Performance

Dec 14, 2017

December 2017 Paper by Ornella Benedettini and Andy Neely on 'Does buyers’ dependen­­ce translate into financial performance? An empirical analysis of manufacturer-service provider relationships­­'

Webinar - Outcome-oriented Contracts and Outsourcing relationships

Dec 11, 2017

Webinar by Florian Urmetzer on 'Using outcome-oriented contracts to foster performance improvements in logistics outsourcing relationships', held on 11 December 2017

View all news

Upcoming events

Ecosystems Strategy One Day Course

Feb 27, 2018

IfM, Cambridge

Shift to Services Executive Education Programme

May 09, 2018

IfM, Cambridge, UK

Upcoming events